Page last updated: 2024-09-04

ampelopsin and Alcoholic Fatty Liver

ampelopsin has been researched along with Alcoholic Fatty Liver in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Miyasaka, K; Shimizu, N; Shimoda, H; Takeda, S; Wu, J; Yamada, W1
Bhatti, AA; Davies, DL; Folk, C; Kim, P; Liang, J; Moradian, R; Silva, J; Spatz, MH; Yu, X1

Other Studies

2 other study(ies) available for ampelopsin and Alcoholic Fatty Liver

ArticleYear
The Anti-Adiposity Mechanisms of Ampelopsin and Vine Tea Extract in High Fat Diet and Alcohol-Induced Fatty Liver Mouse Models.
    Molecules (Basel, Switzerland), 2022, Jan-18, Volume: 27, Issue:3

    Topics: 3T3-L1 Cells; Adiposity; Animals; Anti-Obesity Agents; Antioxidants; Diet, High-Fat; Fatty Liver, Alcoholic; Flavonoids; Lipid Metabolism; Lipogenesis; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Tea

2022
Dihydromyricetin Protects the Liver via Changes in Lipid Metabolism and Enhanced Ethanol Metabolism.
    Alcoholism, clinical and experimental research, 2020, Volume: 44, Issue:5

    Topics: Adenylate Kinase; Animals; Dietary Supplements; Enzyme Activation; Ethanol; Fatty Liver, Alcoholic; Flavonols; Hep G2 Cells; Humans; Lipid Metabolism; Liver; Liver Diseases, Alcoholic; Male; Mice; Mice, Inbred C57BL; Triglycerides

2020